Is Inotiv Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: NOTV) stock is to Buy NOTV stock.
Out of 2 analysts, 1 (50%) are recommending NOTV as a Strong Buy, 0 (0%) are recommending NOTV as a Buy, 1 (50%) are recommending NOTV as a Hold, 0 (0%) are recommending NOTV as a Sell, and 0 (0%) are recommending NOTV as a Strong Sell.
What is NOTV's earnings growth forecast for 2023-2023?
(NASDAQ: NOTV) Inotiv's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.
Inotiv's earnings in 2023 is -$341,294,000.
In 2023, NOTV is forecast to generate $48,699,348 in earnings, with the lowest earnings forecast at $48,699,348 and the highest earnings forecast at $48,699,348.
What is NOTV's forecast return on equity (ROE) for 2023-2023?
(NASDAQ: NOTV) forecast ROE is 17.34%, which is considered weak.
What is NOTV's Price Target?
According to 2 Wall Street analysts that have issued a 1 year NOTV price target, the average NOTV price target is $9.00, with the highest NOTV stock price forecast at $10.00 and the lowest NOTV stock price forecast at $8.00.
On average, Wall Street analysts predict that Inotiv's share price could reach $9.00 by Jan 19, 2024. The average Inotiv stock price prediction forecasts a potential upside of 91.49% from the current NOTV share price of $4.70.
What is NOTV's Earnings Per Share (EPS) forecast for 2023-2023?
(NASDAQ: NOTV) Inotiv's current Earnings Per Share (EPS) is -$13.76. In 2023, NOTV's EPS is forecast to hit $1.90 (min: $1.90, max: $1.90).
What is NOTV's forecast return on assets (ROA) for 2023-2023?
(NASDAQ: NOTV) forecast ROA is 5.59%, which is lower than the forecast US Diagnostics & Research industry average of 9.67%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.